DOC — Healthpeak Properties, Inc.

Healthpeak Properties, Inc. (DOC) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• FFO (Funds From Operations) as adjusted: $0.46 per share
• AFFO (Adjusted Funds From Operations): $0.42 per share
• Year-to-date portfolio same-store growth: 3.8%
• Cash NOI (Net Operating Income): Increased by 9.4% for the quarter
• Total occupancy: 91% (up 10 basis points)
• Lab occupancy: 81%
• CCRC (Continuing Care Retirement Community) occupancy: Increased by 70 basis points sequentially
• Year-to-date leasing volumes: 3.2 million square feet in outpatient medical, 1.1 million square feet in lab space
• Liquidity: $2.7 billion

2. Strategic Updates and Business Highlights

• Healthpeak's merger with Physicians Realty Trust has strengthened its outpatient medical portfolio, growing it by $5 billion.
• Internalization of property management for 39 million square feet allows for better tenant relationships and operational efficiencies.
• The company is exploring the sale of non-core outpatient medical assets, with potential proceeds exceeding $1 billion.
• Significant growth in the leasing pipeline, which has doubled since the beginning of the year, indicating positive demand trends.
• The CCRC business is performing well, with a 50% increase in NOI since acquiring full ownership six years ago.

3. Forward Guidance and Outlook

• Healthpeak reaffirmed its FFO as adjusted and same-store expectations within the original guidance range.
• Anticipates occupancy to decline in the short term due to expirations and terminations, with a potential bottom in the high 70s before recovery begins.
• The company expects to see growth in occupancy and earnings starting in late 2026, driven by recent leasing activity and a robust pipeline.
• Plans to leverage proceeds from outpatient sales into higher-return lab opportunities.

4. Bad News, Challenges, or Points of Concern

• Anticipated decline in occupancy over the next few months due to expirations and tenant terminations.
• The life science sector is still recovering, and the company expects the decline in occupancy to impact earnings in 2026.
• Some tenants are facing challenges in raising capital, which could affect their stability and leasing agreements.
• The company has taken impairments on certain lab joint ventures, reflecting a cautious approach to asset valuations.

5. Notable Q&A Insights

• The lab leasing pipeline has seen a favorable mix of new and renewal tenants, with a significant uptick in demand driven by improved sentiment in the sector.
• Healthpeak is focused on opportunistic acquisitions in both outpatient medical and lab properties, targeting double-digit unlevered IRRs for life science investments.
• The company is seeing a reduction in its watch list of tenants, indicating improved financial health among its tenant base.
• M&A activity in the biotech sector is expected to drive demand for lab space, with a mixed impact on existing tenants depending on the nature of acquisitions.
• Management emphasized a flexible approach to capital allocation, prioritizing balance sheet strength while pursuing strategic investments.

Overall, Healthpeak Properties is navigating a transitional period with positive indicators in outpatient medical and CCRC sectors, while managing challenges in the life science space. The company is strategically positioned to capitalize on market opportunities as conditions improve.